The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 10, 2013
Filed:
Jul. 23, 2009
Dennis Fiegen, Biberach, DE;
Sandra Handschuh, Biberach, DE;
Silke Hobbie, Biberach, DE;
Matthias Hoffmann, Mittelbiberach, DE;
Takeshi Kono, Osaka, JP;
Yayoi Sato, Hyogo, JP;
Andreas Schnapp, Biberach, DE;
Annette Schuler-metz, Ulm, DE;
Dennis Fiegen, Biberach, DE;
Sandra Handschuh, Biberach, DE;
Silke Hobbie, Biberach, DE;
Matthias Hoffmann, Mittelbiberach, DE;
Takeshi Kono, Osaka, JP;
Yayoi Sato, Hyogo, JP;
Andreas Schnapp, Biberach, DE;
Annette Schuler-Metz, Ulm, DE;
Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;
Abstract
The invention relates to novel substituted naphthyridines of formula 1 as well as pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates, or solvates thereof. In formula 1, Rcan represent a group A selected from among the group comprising —O—R, —NRR, —CRRR, -(ethyne)-R, —S—R, —SO—R, and SO—R, or Rrepresents a group B selected from among the group comprising: —C-aryl; —a five-membered to ten-membered, monocyclic or bicyclic heteroaryl containing 1 to 3 heteroatoms independently selected from among the group comprising N, O, and S, wherein said heteroaryl is linked to the structure according to formula 1 via a C atom or an N atom; —a three-membered to ten-membered, monocyclic or bicyclic, saturated or partially saturated heterocycle containing 1 to 3 heteroatoms independently selected from among the group comprising N, O, and S, wherein said heterocycle is linked to the structure according to formula 1 via a C atom or an N atom; and —a 5-membered to 11-membered spiro group which can optionally contain 1, 2, or 3 heteroatoms independently selected from among the group comprising N, O, and S, wherein said spiro group is linked to the structure according to formula 1 via a C atom or an N atom, wherein said group B can be optionally substituted as described in claims, and R, R, R, R, and m can have the meanings indicated in claim. The invention also relates to pharmaceutical compositions containing said compounds.